Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol

Human Reproduction

Volumn 21, Issue 12, 2006, Pages 3091-3095

  Asimakopoulos, Byron ^a   Koster F ^b   Felberbaum, R ^c   Al Hasani, S ^b   Diedrich, K ^b   Nikolettos, Nikos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Department of Gynaecology and Obstetrics   (Germany)

Author keywords

Cytokines; Estradiol; FGF; Ovarian stimulation; Progesterone

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CETRORELIX; CHORIONIC GONADOTROPIN; CYTOKINE; DECAPEPTYL DEPOT; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE; TRIPTORELIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MULTIPLE DRUG DOSE; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PROGESTERONE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 33751371794     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del207     Document Type: Article

References (28)

1. Aboul Enien WM, Lewis-Jones ID and Vince GS (2001) Follicular fluid cytokines and IVF outcome. Middle East Fertil Soc J 6,206-211.
2. Albano C, Felberbaum RE, Smitz J, Riethmüller-Winzen H, Engel J, Diedrich K and Devroey P (2000) Controlled ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the LHRH-antagonist cetrorelix (cetrotide) and the LHRH-agonist buserelin. Hum Reprod 15,526-531.
3. Al-Inany H and Aboulghar M (2002) Gonadotrophin-releasing hormone antagonists in assisted reproduction: A Cochrane review. Hum Reprod 17,874-885.
4. Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, Bellastella A, Carella C and Izzo A (2003) Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 101,1177-1182.
5. Asimakopoulos B, Nikolettos N and Al-Hasani S (2002) Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix. Reprod Biomed Online 5,52s-56s.
6. Asimakopoulos B, Nikolettos N, Papachristou DM, Simopoulou M, Al-Hasani S and Diedrich K (2005) Follicular fluid levels of vascular endothelial growth factor and leptin are associated with pregnancy outcome of normal women participating in intracytoplasmic sperm injection cycles. Physiol Res 54,263-270.
7. Barak V, Mordel N, Holzer H, Zajicek G, Treves AJ and Laufer N (1992) The correlation of interleukin 1 and tumour necrosis factor to oestradiol, progesterone and testosterone levels in periovulatory follicular fluid of in-vitro fertilization patients. Hum Reprod 7,462-464.
8. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR and Agarwal A (2002) Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod 17,426-431.
9. Borm G and Mannaerts BMJL (2000) Treatment with the gonadotrophinreleasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 15,1490-1498.
10. Büscher U, Chen FCK, Kentenich H and Schmiady H (1999) Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction? Hum Reprod 14,162-166.
11. Calogero AE, Nicoletti F, Palumbo MA, Burrello N, Di Mauro M, Lunetta M, Bendtzen K and Cianci A (1998) Macrophage-derived cytokines in the follicular fluids of women with infertility due to immunological causes. Elevated levels of interleukin 6 and low levels of granulocyte-macrophage colony-stimulating factor. Cytokine 10,814-818.
12. Cianci A, Calogero AE, Palumbo MA, Burrello N, Ciotta L, Palumbo G and Bernardini R (1996) Relationship between tumour necrosis factor α and sex steroid concentrations in the follicular fluid of women with immunological infertility. Hum Reprod 11,265-268.
13. Diedrich K and Felberbaum R (1998) New approaches to ovarian stimulation. Hum Reprod 13,1s-13s.
14. European-Middle East Orgalutran Study Group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16,644-651.
15. Felberbaum RE, Albano C, Ludwig M, Riethmüller-Winzen H, Grigat M, Devroey P and Diedrich K (2000) Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: A prospective uncontrolled phase III study. Hum Reprod 15,1015-1020.
16. Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT, Schoolcraft W et al. (2001) Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 75,38-45.
17. Ludwig M, Felberbaum RE and Diedrich K (1999) Interactions of GnRH analogues and gonadotrophins. In Adashi EY, Baird DT and Crosignani PG (eds) Gonadotrophins and Fertility, Vol. 1. Christengraf, Rome, pp. 125-143.
18. Ludwig M, Felberbaum RE and Diedrich K (2000) LHRH antagonist protocols in IVF do not lead to worse results than the long LHRH agonist protocol. Ref Gynecol Obstet 7,249-250.
19. Lynch K, Fernandez G, Pappalardo A and Peluso JJ (2000) Basic fibroblast growth factor inhibits apoptosis of spontaneously immortalized granulosa cells by regulating intracellular free calcium levels through a protein kinase Cδ-dependent pathway. Endocrinology 141,4209-4217.
20. Nilsson E, Parrott JA and Skinner MK (2001) Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesis. Mol Cell Endocrinol 175,123-130.
21. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L, Nicollet B, Zorn JR, Bouchard P and Frydman R (2000) A prospective randomized controlled study in IVF-ET with a single dose of a LH-RH antagonist (cetrorelix) or a depot formula of a LH-RH agonist (triptorelin). Fertil Steril 73,314-320.
22. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J and Simón C (1998) The follicular and endocrine environment in women with endometriosis: Local and systemic cytokine production. Fertil Steril 70,425-431.
23. Peluso JJ and Pappalardo A (1999) Progesterone maintains large rat granulosa cell viability indirectly by stimulating small granulosa cells to synthesize basic fibroblast growth factor. Biol Reprod 60,290-296.
24. Punnonen J, Heinonen PK, Teisala K, Kujansuu E, Jansen CT and Punnonen R (1992) Demonstration of tumor necrosis factor-alpha in preovulatory follicular fluid: Its association with serum 17 beta-estradiol and progesterone. Gynecol Obstet 33,80-84.
25. Reynolds LP and Redmer DA (1998) Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary. J Anim Sci 76,1671-1681.
26. Roulier R, Chabert-Orsini V, Sitri MC, Barry B and Terriou P (2003) Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment. Reprod Biomed Online 7,185-189.
27. Shikone T, Yamoto M and Nakano R (1992) Follicle-stimulating hormone induces functional receptors for basic fibroblast growth factor in rat granulosa cells. Endocrinology 131,1063-1068.
28. Wang LJ, Brännström M, Robertson SA and Norman RJ (1992) Tumor necrosis factor α in the human ovary: Presence in follicular fluid and effects on cell proliferation and prostaglandin production. Fertil Steril 58,934-940.